We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.35%
This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+16.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$136B
AUM Growth
+$7.83B
Cap. Flow
+$9.38B
Cap. Flow %
6.92%
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,063
Increased
4,755
Reduced
3,911
Closed
1,116

Sector Composition

Rank Sector Weight
1 Energy 8.49%
2 Technology 6.67%
3 Healthcare 6.67%
4 Financials 6.58%
5 Industrials 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKX icon
1901
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$664M
$5.62M ﹤0.01%
403,221
+107,585
+36% +$1.48M
DCUA
1902
DELISTED
DOMINION RESOURCES INC. CORP UNIT 2013 SER A (VA)
DCUA
$5.61M ﹤0.01%
100,000
-75,875
-43% -$4.29M
VIV icon
1903
Telefônica Brasil
VIV
$18.5B
$5.61M ﹤0.01%
284,817
+16,271
+6% +$329K
HEES
1904
DELISTED
H&E Equipment Services
HEES
$5.6M ﹤0.01%
139,023
-9,185
-6% -$358K
CPWR
1905
DELISTED
COMPUWARE CORP
CPWR
$5.6M ﹤0.01%
549,108
+491,734
+857% +$4.63M
VSTM icon
1906
Verastem
VSTM
$629M
$5.59M ﹤0.01%
54,702
+21,080
+63% +$2.21M
RH icon
1907
RH
RH
$3.41B
$5.58M ﹤0.01%
70,161
+53,636
+325% +$4.48M
PGR icon
1908
Progressive
PGR
$121B
$5.58M ﹤0.01%
220,575
+76,738
+53% +$1.89M
SCHO icon
1909
Schwab Short-Term US Treasury ETF
SCHO
$12.9B
$5.57M ﹤0.01%
220,132
+7,202
+3% +$182K
NRK icon
1910
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$918M
$5.56M ﹤0.01%
434,060
+38,524
+10% +$500K
EWQ icon
1911
iShares MSCI France ETF
EWQ
$333M
$5.55M ﹤0.01%
209,207
+34,007
+19% +$939K
EA
1912
PUT
DELISTED
Electronic Arts
EA
$5.55M ﹤0.01%
155,800
+5,100
+3% +$186K
ULTI
1913
PUT
DELISTED
Ultimate Software Group Inc
ULTI
$5.55M ﹤0.01%
39,200
+24,700
+170% +$3.46M
HPS
1914
John Hancock Preferred Income Fund III
HPS
$463M
$5.54M ﹤0.01%
316,598
-68,650
-18% -$1.21M
LNT icon
1915
Alliant Energy
LNT
$18.2B
$5.54M ﹤0.01%
200,112
-131,498
-40% -$3.79M
DX
1916
Dynex Capital
DX
$3.22B
$5.53M ﹤0.01%
228,132
-11,392
-5% -$289K
VAL
1917
DELISTED
Valspar
VAL
$5.52M ﹤0.01%
69,919
+9,978
+17% +$783K
MET icon
1918
CALL
MetLife
MET
$61.4B
$5.52M ﹤0.01%
115,342
+4,152
+4% +$202K
CLVS
1919
DELISTED
Clovis Oncology, Inc.
CLVS
$5.51M ﹤0.01%
121,579
+68,356
+128% +$2.86M
WFM
1920
CALL
DELISTED
Whole Foods Market Inc
WFM
$5.51M ﹤0.01%
144,516
-51,184
-26% -$1.96M
NBG.PRA
1921
DELISTED
NATIONAL BANK OF GREECE SA SPON ADR PFD REPSTG SER A
NBG.PRA
$5.51M ﹤0.01%
286,461
+1,205
+0.4% +$23.3K
DHR icon
1922
CALL
Danaher
DHR
$145B
$5.49M ﹤0.01%
107,570
+101,916
+1,803% +$5.24M
J icon
1923
Jacobs Solutions
J
$17B
$5.49M ﹤0.01%
136,032
-197,269
-59% -$8.6M
ACWV icon
1924
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.37B
$5.49M ﹤0.01%
82,270
-46,650
-36% -$3.14M
WBA
1925
CALL
DELISTED
Walgreens Boots Alliance
WBA
$5.49M ﹤0.01%
92,600
-193,000
-68% -$12.7M

Similar funds

UBS's Q3 2014 Portfolio in Review

As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS deployed $9.38B of net new capital in Q3 2014, opening 1,063 new positions and adding to 4,755 existing holdings. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M.

By sector, the portfolio is most concentrated in Energy at 8.5% of assets, down from 8.8% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B trimmed.

  • UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
  • UBS added most to Amgen in Q3 2014, an estimated $387M increase.
  • UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
  • UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
  • UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
  • UBS opened 1,063 new positions and closed 1,116 in Q3 2014.
  • UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.